Загрузка...
Should Low Molecular Weight PSMA Targeted Ligands Get Bigger and Use Albumin Ligands for PSMA Targeting?
Prostate Specific Membrane Antigen (PSMA) is strongly expressed in prostate cancer. Recently a number of low-molecular-weight inhibitors have demonstrated excellent PSMA targeting activity for both imaging as well as Lutecium-177 radiotherapy in human trials. The paper by Choy et al raises the quest...
Сохранить в:
| Опубликовано в: : | Theranostics |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Ivyspring International Publisher
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5479280/ https://ncbi.nlm.nih.gov/pubmed/28638479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.20284 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|